Thursday, January 16, 2025
HomeTagsNovel prophylactic therapeutics

novel prophylactic therapeutics

Hemab Therapeutics Names Kate Madigan, MD, as CMO

Hemab Therapeutics, a clinical-stage biotechnology company developing novel prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders, announced the appointment of Kate Madigan, MD,...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics